This GBM-specific macrophage subset might be supported by a glioma-characteristic lipid mediator (LM) milieu of enriched docosahexaenoic acid (DHA) and its lipoxygenase (LOX)-derived metabolites. The gene discussed is LOX; the disease is glioma.